Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent oral levetiracetam for prevention of recurrent febrile seizures in children
IRCT20130812014333N170Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levetiracetam in febrile seizure (FS) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Fever and Convulsions. Started May 2021; status: completed.
02
Drugs
levetiracetam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20130812014333N170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N170.